Aevis Victoria SA (SWX:AEVS)
Switzerland
· Delayed Price · Currency is CHF 14.00
+0.50 (3.70%)
Mar 9, 2026, 5:36 PM CET
Aevis Victoria Revenue
Aevis Victoria had revenue of 535.89M CHF in the half year ending June 30, 2025, with 25.21% growth. This brings the company's revenue in the last twelve months to 955.96M, up 10.12% year-over-year. In the year 2024, Aevis Victoria had annual revenue of 883.16M with 6.02% growth.
Revenue (ttm)
955.96M
Revenue Growth
+10.12%
P/S Ratio
1.24
Revenue / Employee
202.06K
Employees
4,731
Market Cap
1.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 883.16M | 50.15M | 6.02% |
| Dec 31, 2023 | 833.02M | -133.85M | -13.84% |
| Dec 31, 2022 | 966.86M | 221.95M | 29.79% |
| Dec 31, 2021 | 744.92M | 119.97M | 19.20% |
| Dec 31, 2020 | 624.94M | 1.75M | 0.28% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 44.94B |
| Galderma Group AG | 4.16B |
| Lonza Group AG | 6.53B |
| Cosmo Pharmaceuticals | 170.24M |
| Tecan Group AG | 906.60M |
| SKAN Group AG | 332.13M |
| Medartis Holding AG | 236.34M |
Aevis Victoria News
- 6 months ago - Aevis Victoria SA (XSWX:AEVS) Half Year 2025 Earnings Call Highlights: Strong Growth and ... - GuruFocus
- 6 months ago - Half Year 2025 Aevis Victoria SA Earnings Call Transcript - GuruFocus